参见附件。
doi：10.3969/j.issn.1007-614x.2014.23.53
摘 要 目的：探讨米氮平和帕罗西汀在首发抑郁症治疗中的应用效果。方法：2012年1月-2013年12月收治首发抑郁症患者64例，分为米氮平组和帕罗西汀组，各32例。结果：两组临床疗效差异无统计学意义(P>0.05)；治疗后两组汉密尔顿抑郁量表(HAMD)评分均较治疗前差异有统计学意义(P0.05)。结论：米氮平和帕罗西汀治疗首发抑郁症疗效相当，可有效改善患者抑郁状态，均可作为首选用药。
关键词 米氮平 帕罗西汀 首发抑郁症
Application of mirtazapine and paroxetine in the treatment of first-episode depression
Zhang Hui
Department of Psychiatry，the Fifth People's Hospital of Kaifeng，Henan 453003
Abstract Objective： To investigate the application effect of mirtazapine and paroxetine in the treatment of first-episode depression.Methods：64 cases with first-episode depressive were selected from January 2012 to December 2013 ......
